Correction: The effect of NOTCH3 pathogenic variant position on CADASIL disease severity: NOTCH3 EGFr 1-6 pathogenic variant are associated with a more severe phenotype and lower survival compared with EGFr 7-34 pathogenic variant

Affiliations

• ¹ CADASIL Research Group, Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands. [email protected].
• ² Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands. [email protected].
• ³ CADASIL Research Group, Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.
• ⁴ Institute for Stroke and Dementia Research, University Hospital (LMU), Munich, Germany.
• ⁵ Department of Neurology, AP-HP, Lariboisière Hospital, Paris, France.
• ⁶ Department of Neurology, SLK-Kliniken Heilbronn, Heilbronn, Germany.
• ⁷ "L. Sacco" Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.
• ⁸ Department of Medicine, Surgery and Neurosciences, Medical School, University of Siena, Siena, Italy.
• ⁹ Stroke Research Group, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.